50
Participants
Start Date
October 31, 2010
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
National Multiple Sclerosis Society
OTHER
Biogen
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER